Send me real-time posts from this site at my email

Buy Teva

TEVA's recent correction reflected the analysts/big boys being able to monitor the slightly disappointing revenue growth.

What we see today, that they couldn't as easily follow, is the continued improved performance.

Another $500 Million lopped off the net debt this quarter, now down to $22.7 Billion. Reaffirmed FCF guidance of 2.0-2.3 Billion will continue this deleveraging.

That's \/SHARE"}==!>, which equates to an increase in intrinsic value of TEVA stock of $2 plus perhaps another $2 from the de-risking that entails. That's quite a nice % increase on the current low stock price.

Buy Teva.

$TEVA, Teva Pharmaceutical Industries Limited / H1


Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue